These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 15566000)
1. [Outcome of pulmonary Mycobacterium avium complex (MAC) disease treated with clarithromycin (CAM)-containing regimens]. Shirai M; Hayakawa H; Nakano Y; Kuroishi S; Nakano Y; Todate A; Suda T; Chida K Nihon Kokyuki Gakkai Zasshi; 2004 Oct; 42(10):875-9. PubMed ID: 15566000 [TBL] [Abstract][Full Text] [Related]
2. Factors that affect sputum conversion and treatment outcome in patients with Mycobacterium avium-intracellulare complex pulmonary disease. Ye JJ; Wu TS; Chiang PC; Lee MH J Microbiol Immunol Infect; 2007 Aug; 40(4):342-8. PubMed ID: 17712469 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study. Miwa S; Shirai M; Toyoshima M; Shirai T; Yasuda K; Yokomura K; Yamada T; Masuda M; Inui N; Chida K; Suda T; Hayakawa H Ann Am Thorac Soc; 2014 Jan; 11(1):23-9. PubMed ID: 24298907 [TBL] [Abstract][Full Text] [Related]
4. [Effect of combined chemotherapy following the guidelines on treatment for Mycobacterium avium complex pulmonary disease]. Kobashi Y; Okimoto N; Matsushima T; Shigetou E; Kuraoka T; Takeyama H; Eda R; Yano S; Kobayashi K; Ohnishi T; Mori K; Ueda Y; Moritaka T; Nishimura K; Abe T Kekkaku; 2002 Jun; 77(6):435-41. PubMed ID: 12136597 [TBL] [Abstract][Full Text] [Related]
5. Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease. Kadota T; Matsui H; Hirose T; Suzuki J; Saito M; Akaba T; Kobayashi K; Akashi S; Kawashima M; Tamura A; Nagai H; Akagawa S; Kobayashi N; Ohta K BMC Infect Dis; 2016 Jan; 16():31. PubMed ID: 26818764 [TBL] [Abstract][Full Text] [Related]
6. Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease. Tanaka E; Kimoto T; Tsuyuguchi K; Watanabe I; Matsumoto H; Niimi A; Suzuki K; Murayama T; Amitani R; Kuze F Am J Respir Crit Care Med; 1999 Sep; 160(3):866-72. PubMed ID: 10471610 [TBL] [Abstract][Full Text] [Related]
7. Early pulmonary resection for Mycobacterium avium complex lung disease treated with macrolides and quinolones. Watanabe M; Hasegawa N; Ishizaka A; Asakura K; Izumi Y; Eguchi K; Kawamura M; Horinouchi H; Kobayashi K Ann Thorac Surg; 2006 Jun; 81(6):2026-30. PubMed ID: 16731124 [TBL] [Abstract][Full Text] [Related]
8. [Clinical features and treatment history of clarithromycin resistance in M. avium-intracellulare complex pulmonary disease patients]. Kuwabara K; Tsuchiya T Nihon Kokyuki Gakkai Zasshi; 2007 Aug; 45(8):587-92. PubMed ID: 17763685 [TBL] [Abstract][Full Text] [Related]
9. Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates. Kobashi Y; Yoshida K; Miyashita N; Niki Y; Oka M J Infect Chemother; 2006 Aug; 12(4):195-202. PubMed ID: 16944258 [TBL] [Abstract][Full Text] [Related]
10. Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex. Griffith DE; Brown BA; Cegielski P; Murphy DT; Wallace RJ Clin Infect Dis; 2000 Feb; 30(2):288-92. PubMed ID: 10671330 [TBL] [Abstract][Full Text] [Related]
11. Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease. Griffith DE; Brown-Elliott BA; Langsjoen B; Zhang Y; Pan X; Girard W; Nelson K; Caccitolo J; Alvarez J; Shepherd S; Wilson R; Graviss EA; Wallace RJ Am J Respir Crit Care Med; 2006 Oct; 174(8):928-34. PubMed ID: 16858014 [TBL] [Abstract][Full Text] [Related]